Data Bridge Market Research has recently added concise research on the Vaccine Market report to depict valuable insights related to significant market trends driving the industry. The Global Vaccine Market report makes available the basic information about industry, definition, classification, application, industry chain structure, industry overview and international market analysis.

In recent years, the vaccine market is anticipated to grow rapidly during the forecast period of 2022-2029 due to the emergence of the COVID-19 pandemic. Vaccine technology has advanced dramatically in the recent decade, significantly altering the future of vaccine development. Many improvements in vaccine development programmes have been spurred by the introduction of genetic engineering, resulting in new products.

A vaccine allows a person to be exposed to a pathogen in a controlled manner. Governments all across the world have been concentrating their efforts on reducing global disease burdens, particularly for vaccine-preventable diseases. Vaccination has also been regarded as the first line of defense in the event of an endemic or pandemic outbreak, which could result in healthcare issues.

Drivers

Prevalence of infectious diseases will increase market demand.

The rise in the prevalence rate of emerging and re-emerging infectious diseases act as a major driver that will result in the expansion of the growth rate of the treatment market.

Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of vaccine market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness about new treatment options, and growing government funding for vaccine development are the factors that will expand the vaccine market. Other factors such as growing geriatric population and rising focus on immunization development will positively impact the vaccine market's growth rate. Additionally, high disposable income, continuously changing lifestyle and high target affinity and specificity will result in the expansion of the vaccine market.

Table of Contents:

Global Vaccine Market Overview
Economic Impact on Industry
Competition by Manufacturers
Production, Revenue (Value) by Region
Supply (Production), Consumption, Export, Import by Regions
Production, Revenue (Value), Price Trend by Type
Market by Application
Manufacturing Cost Analysis
Industrial Chain, Sourcing Strategy and Downstream Buyers
Marketing Strategy Analysis, Distributors/Traders
Market Effect Factors Analysis
Market Forecast
Appendix

List of Figures:

Figure 1 Global Vaccine Market: Segmentation

Figure 2 Global Vaccine Market: Data Triangulation

Figure 3 Global Vaccine Market: Droc Analysis

Figure 4 Global Vaccine Market: Global Vs Regional Market Analysis

Figure 5 Global Vaccine Market: Company Research Analysis

Figure 6 Global Vaccine Market: Interview Demographics

Figure 7 Global Vaccine Market: DBMR Market Position Grid

Figure 8 Global Vaccine Market: Vendor Share Analysis

Figure 9 Global Vaccine market: Segmentation

Figure 10 North America Is Expected to Dominate and Asia-Pacific Is the Fastest Growing Region in the Global Vaccine Market in the Forecast To 2028

Continued...

The vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine market.

Some of the major players operating in the vaccine market are Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, DAIICHI SANKYO COMPANY, LIMITED, Mitsubishi Tanabe Pharma Corporation, Sun Pharmaceutical Industries Ltd., Sanofi, CSL Limited, Panacea Biotec, EMERGENT, Novavax, Inc., INOVIO Pharmaceuticals, Bavarian Nordic, Sinovac Biotech Ltd., Bharat Biotech, Biotec, Serum Institute of India Pvt. Ltd., AstraZeneca, Johnson & Johnson Private Limited, and Indian Immunologicals Ltd., among others.